BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• Domrex Pharma Inc. Expands Presence in the United States

  Domrex Pharma Inc., a leading manufacturer and distributor of medical supplies in Canada, is thrilled to announce the acceleration of its expansion into the United States.

  February 1, 2024

   · 

  1 min read
• Business

  Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments

  Enzo Biochem, Inc., a leading life science company, announced the voting results from its Annual Meeting held on January 31, 2024 and officer appointments.

  February 1, 2024

   · 

  3 min read
• Business

  Seer to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024

  Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that it will report financial results for the fourth quarter and full year 2023 on Thursday, February 29, 2024.

  February 1, 2024

   · 

  1 min read
• Biotech Bay

  Nurix Therapeutics Announces Publication in the Journal Science Identifying a New Class of BTK Mutations That Are Susceptible to NX-2127, a Novel BTK and IKZF1/3 Degrader

  Nurix Therapeutics, Inc. announced the publication of a manuscript in the journal Science titled: “Kinase Impaired BTK Mutations Are Susceptible to Clinical Stage BTK and IKZF1/3 Degrader NX-2127”.

  February 1, 2024

   · 

  8 min read
• Business

  AVITA Medical to Announce Fourth Quarter and Full Year 2023 Financial Results

  AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) today announced that it will report its fourth quarter and full year 2023 financial results after the close of the U.S. financial markets on Thursday, February 22, 2024.

  February 1, 2024

   · 

  2 min read
• Business

  Guardant Health to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024

  Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the fourth quarter and full year 2023 after market close on Thursday, February 22, 2024.

  February 1, 2024

   · 

  1 min read
• Business

  ARCA biopharma Announces 2023 Financial Results

  ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today reported 2023 financial results and provided a corporate update.

  February 1, 2024

   · 

  6 min read
• Biotech Beach

  Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 01, 2024

  Zentalis® Pharmaceuticals, Inc. announced that on February 1, 2024, the Compensation Committee of Zentalis’ Board of Directors granted non-qualified stock options to purchase an aggregate of 451,250 shares of the Company’s common stock and 165,000 restricted stock units to six newly hired employees.

  February 1, 2024

   · 

  2 min read
• Anbio Biotechnology to showcase ABO & Rhd Blood Grouping Kit at Medlab Middle East 2024

  Anbio Biotechnology (“Anbio”), a leading global diagnostic device and assay company, today announced the company will showcase

  February 1, 2024

   · 

  2 min read
• Xinhua Silk Road: Pien Tze Huang, Beijing Tong Ren Tang agree to boost bilateral cooperation, promote high-quality development of TCM

  Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. signed a cooperation agreement with Beijing Tong Ren Tang Group during the First Conference of Partners of Tong Ren Tang, which was held in Beijing from January 17 to 19.

  February 1, 2024

   · 

  1 min read